SBHCI4:27Percutaneous treatment of tricuspid regurgitation
- Source
- TV SBHCI · YouTube
- Date
- Audio
- Portuguese
- Subtitles
- MultilingualYouTube
- Audio transl.
- Unconfirmed · check ⚙YouTube
Medical notice: Educational content only. CanduCardio is intended for healthcare professionals and CanduTV for the general public. It does not replace clinical judgment or professional consultation.
If you don't see subtitles in your language, turn on auto-translate from the player's settings gear (⚙).
Subtitles requested in: English
First try the player's auto-translate: settings gear (⚙) → Subtitles/CC → Auto-translate. If the video has no subtitles at all, your phone or browser can write out what is said in real time. It runs on your own device: CanduCardio receives and stores nothing.
Original title: La SEC te lleva a ACC22 [IN] ∙ The Corevalve US Pivotal And SURTAVI Trials
Machine-translated title; it may contain inaccuracies.
SURTAVI2017
In intermediate-risk patients with severe aortic stenosis, self-expanding TAVI was noninferior to surgical valve replacement for death or disabling stroke at 24 months.
In aortic stenosis at increased surgical risk, self-expanding TAVR achieved lower one-year mortality than surgical valve replacement.
Educational video published by Sociedad Española de Cardiología in 2022. Played with YouTube's official player.
SBHCI4:27
CACI2:19:32
CACI2:41:58
SBHCI27:26
SEC1:16
SEC31:12
SEC34:53
SEC29:43